{"id":316172,"date":"2021-03-16T10:48:56","date_gmt":"2021-03-16T09:48:56","guid":{"rendered":"https:\/\/www.pcnen.com\/portal\/?p=316172"},"modified":"2021-03-16T10:49:22","modified_gmt":"2021-03-16T09:49:22","slug":"ruski-lijek-protiv-korone-pred-drugom-fazom-ispitivanja","status":"publish","type":"post","link":"https:\/\/www.pcnen.com\/portal\/2021\/03\/16\/ruski-lijek-protiv-korone-pred-drugom-fazom-ispitivanja\/","title":{"rendered":"Ruski lijek protiv korone pred drugom fazom ispitivanja"},"content":{"rendered":"<p>Haitov, koji je \u010dlan Ruske akademije nauka, rekao je za Ra\u0161a tudej da \u0107e se efikasnost lijeka prou\u010davati tokom druge faze ispitivanja, ali je istakao da je te\u0161ko re\u0107i kada \u0107e biti gotovo ispitivanje.<\/p>\n<p>&#8220;Ulo\u017ei\u0107emo sav trud da \u0161to prije po\u010dnemo drugu fazu, a za to postoje svi preduslovi, jer se lijek pokazao vrlo efikasnim tokom faze pretklini\u010dkog ispitivanja. Registrova\u0107emo ga \u010dim druga faza bude gotova, nadam se ove godine&#8221;, naglasio je Haitov.<\/p>\n<p>Prema njegovim rije\u010dima, rezultati testiranja bi\u0107e objavljeni kako u Rusiji tako i u inostranstvu, prenosi agencija TASS.<\/p>\n<p>Direktorka Agencije Veronika Skvorcova izjavila je ranije da je lijek &#8220;mir-19&#8221; zasnovan na mikro ribonukleinskoj kiselini (RNK) koja blokira odre\u0111ene djelove virusne RNK.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ruska Savezna medicinsko-biolo\u0161ka agencija nada se da \u0107e njen lijek protiv korona virusa &#8220;mir-19&#8221; biti registrovan ove godine, izjavio je direktor Instituta za imunologiju pri toj agenciji Musa Haitov.<\/p>\n","protected":false},"author":1,"featured_media":287469,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-316172","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti"],"_links":{"self":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/316172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/comments?post=316172"}],"version-history":[{"count":2,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/316172\/revisions"}],"predecessor-version":[{"id":316174,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/316172\/revisions\/316174"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media\/287469"}],"wp:attachment":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media?parent=316172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/categories?post=316172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/tags?post=316172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}